Artemis Medicare Services DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.75×	0.75×	0.76×	0.72×	0.75×
	0.99×	0.99×	1.01×	0.74×	0.80×
	13.5%	13.0%	11.4%	10.5%	8.5%
	0.78×	0.78×	0.80×	0.94×	0.91×
	1.61×	1.52×	1.61×	2.14×	2.22×
	12.5%	11.4%	11.3%	11.2%	10.4%
	11.7%	11.7%	12.9%	11.5%	9.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ARTEMISMED₹297.95

Artemis Medicare Services Limited

· Pharma & Health

₹ CrorePeersINDRAMEDCO SHALBY GKSL GPTHEALTH LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹4,717 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.75	0.72	0.76	0.75	0.75
Interest Burden (Pretax/EBIT) ×	0.80	0.74	1.01	0.99	0.99
EBIT Margin %	8.54	10.52	11.38	12.96	13.48
Asset Turnover ×	0.91	0.94	0.80	0.78	0.78
Financial Leverage (Assets/Equity) ×	2.22	2.14	1.61	1.52	1.61
ROE (5-step product, year-end total equity) %	10.41	11.23	11.29	11.36	12.53
ROE (owners' profit / average owners' equity) %	9.41	11.54	12.85	11.69	11.69

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.